Clinical Data Access Fee. In consideration for the transfer of Clinical Data from four (4) Trial Subjects from INSERM to LICENSEE and the access to Clinical Data granted to LICENSEE pursuant to the License Agreement and this Amendment No. 2, LICENSEE shall pay to INSERM-TRANSFERT the total sum of [***]. Invoices are to be submitted to LICENSEE by email to: [***]. Installments will be paid within thirty (30) days of receipt of an invoice as follows: (i) [***]; (ii) [***]; (iii) [***], and (iv) [***].β
Appears in 2 contracts
Sources: Patent and Know How License Agreement (Bluebird Bio, Inc.), Patent and Know How License Agreement (Bluebird Bio, Inc.)